PERRIGO CO
Display and export data
General & Ratios
Financial Statements
/
In the 'original' view, the statements are displayed just as they are being reported by the company.
In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).
Add data
Click on one of the orange fields in the profile to add new information
Edit or review data
Legend (for Financial Statements)
Passed value check (?)
Failed value check (?)
Click on a coloured field in the profile to review the data
Close sidebar
Loading: 100%
PERRIGO CO logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 12,800 (as per Q2 2014)no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker PRGOno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1760708090100
datesClosing price (adj.)
13.10.201787.78
11.10.201787.31
04.10.201786.69
27.09.201785.14
20.09.201785.48
13.09.201789.01
06.09.201778.33
30.08.201777.52
23.08.201777.42
16.08.201779.02
09.08.201766.23
02.08.201771.98
26.07.201776.08
19.07.201772.50
12.07.201773.13
05.07.201774.55
27.06.201774.55
20.06.201772.21
13.06.201771.55
06.06.201770.19
30.05.201767.78
23.05.201772.76
16.05.201774.23
09.05.201774.41
02.05.201775.90
25.04.201767.52
18.04.201765.86
11.04.201768.71
04.04.201766.38
28.03.201768.62
21.03.201767.85
14.03.201769.00
07.03.201770.00
28.02.201774.29
21.02.201784.13
14.02.201781.60
07.02.201777.26
31.01.201775.66
24.01.201771.46
17.01.201776.06
10.01.201783.11
03.01.201785.95
27.12.201684.64
19.12.201684.01
12.12.201681.77
05.12.201684.12
28.11.201687.63
21.11.201688.59
14.11.201690.81
07.11.201683.29
31.10.201682.52
24.10.201689.88
17.10.201685.74
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
 87.78n/a
Market Capitalisation
in million USD
 8,278n/a
Enterprise Value
in million USD
 9,445n/a
Common Shares Outstanding
as per Sep 28, 2013
 94,300,000n/a
Preferred Shares Outstanding
as per Sep 28, 2013
 n/a
Average Basic Shares Outstanding
TTM
 94,049,250n/a
Average Diluted Shares Outstanding
TTM
 94,612,500n/a
Index Membership
n/a
Business Summary
Perrigo Co PLC is a healthcare company providing branded OTC products throughout Europe and the USA. It sells its products primarily in North America and Europe, as well as in other markets, including Australia, Israel and China.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2013, million USD, full statements further below)
Profit & Loss
Revenues 3,703n/a
Gross Profit 1,351n/a
Operating Income 716n/a
EBITDA 891n/a
Net Profit 448n/a
Balance Sheet
Cash and Cash Equivalents 817n/a
Receivables 703n/a
Total Current Assets 2,367n/a
PP&E 691n/a
Total Assets 5,509n/a
Accounts Payable 304n/a
Current Debt 47n/a
Total Current Liabilities 744n/a
Long-Term Debt 1,936n/a
Total Liabilities 3,039n/a
Total Equity 2,470n/a
Cash Flow
Depreciation & Amortisation 175n/a
Change in Working Capital -36n/a
Operating Cash Flow 608n/a
Net Change in PP&E and Intangibles -125n/a
Investing Cash Flow -969n/a
Dividends Paid -34n/a
Financing Cash Flow 549n/a
Total Change in Cash 185n/a
Free Cash Flow 553n/a
Profitability Ratios
Gross Margin 36.5%n/a
Operating Margin 19.3%n/a
Net Profit Margin 12.1%n/a
Return on Equity 18.1%n/a
Return on Assets 8.1%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 10.60n/a
EV/Sales 2.55n/a
Book to Market Value 0.30n/a
Other Ratios
Current Ratio 318.4%n/a
Liabilities to Equity Ratio 123.0%n/a
Debt to Assets Ratio 36.0%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13
Revenue
2,006
2,268
2,755
3,173
3,540
Sales & Services Revenue
0
0
0
0
0
Financing Revenue
0
0
0
0
0
Other Revenue
0
0
0
0
0
Cost of revenue
-1,408
-1,522
-1,810
-2,078
-2,260
Cost of Goods & Services
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
Gross Profit
597
746
945
1,096
1,280
Other Operating Income
0
0
0
0
0
Operating Expenses
-333
-382
-454
-518
-589
Selling, General & Administrative
-256
-298
-364
-412
-474
Selling & Marketing
0
0
0
0
0
General & Administrative
0
0
0
0
0
Research & Development
-77
-84
-89
-106
-115
Depreciation & Amortization
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
Operating Income (Loss)
264
364
491
578
691
Non-Operating Income (Loss)
-28
-27
-40
-57
-67
Interest Expense, net
-27
-28
-42
-61
-66
Interest Expense
0
0
0
0
0
Interest Income
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
Other Non-Operating Income (Loss)
-1
1
3
4
-1
Pretax Income (Loss), Adjusted
236
337
452
521
624
Abnormal Gains (Losses)
-30
-29
-1
-9
-17
Acquired In-Process R&D
0
-19
0
0
-9
Merger / Acquisition Expense
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
Sale of Business
0
0
0
0
0
Legal Settlement
0
0
0
0
0
Restructuring Charges
-15
-10
-1
-9
-3
Sale of and Unrealized Investments
-15
0
0
0
-5
Insurance Settlement
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
Pretax Income (Loss)
206
309
451
512
608
Income Tax (Expense) Benefit, net
-63
-84
-110
-119
-166
Current Income Tax
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
Income (Loss) from Continuing Operations
143
224
341
393
442
Net Extraordinary Gains (Losses)
3
-1
-1
9
0
Discontinued Operations
3
-1
-1
9
0
XO & Accounting Charges & Other
0
0
0
0
0
Income (Loss) Including Minority Interest
146
224
339
402
442
Minority Interest
0
0
0
0
0
Net Income
146
224
339
402
442
Preferred Dividends
0
0
0
0
0
Other Adjustments
0
0
0
0
0
Net Income Available to Common Shareholders
146
224
339
402
442
Remarks
restated on Aug 16, 2011 n/a
calculated values,
restated on Aug 16, 2012 n/a
calculated values,
restated on Aug 15, 2013 n/a
calculated values,
restated on Aug 15, 2013 n/a
calculated values,
restated on Aug 15, 2013 n/a
calculated values,
Balance SheetBS data quality: 91% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
110
310
603
780
Cash & Cash Equivalents
n/a
110
310
603
780
Short Term Investments
n/a
1
0
0
0
Accounts & Notes Receivable
n/a
360
478
573
652
Accounts Receivable, Net
n/a
360
478
573
652
Notes Receivable, Net
n/a
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
Inventories
n/a
453
506
548
704
Raw Materials
n/a
0
0
0
0
Work In Process
n/a
0
0
0
0
Finished Goods
n/a
0
0
0
0
Other Inventory
n/a
0
0
0
0
Other Short Term Assets
n/a
480
84
73
101
Prepaid Expenses
n/a
31
50
27
48
Derivative & Hedging Assets
n/a
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
Deferred Tax Assets
n/a
27
30
46
47
Income Taxes Receivable
n/a
14
0
1
6
Discontinued Operations
n/a
7
3
0
0
Miscellaneous Short Term Assets
n/a
400
0
0
0
Total Current Assets
n/a
1,403
1,377
1,796
2,237
Property, Plant & Equipment, Net
n/a
1,334
1,513
1,697
681
Property, Plant & Equipment
n/a
1,770
2,012
2,238
1,290
Accumulated Depreciation
n/a
-437
-498
-541
-609
Long Term Investments & Receivables
n/a
0
0
0
0
Long Term Investments
n/a
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
Other Long Term Assets
n/a
1,258
1,305
1,650
2,433
Intangible Assets
n/a
0
0
0
0
Goodwill
n/a
618
645
820
1,174
Other Intangible Assets
n/a
587
568
729
1,158
Prepaid Expense
n/a
0
0
0
0
Deferred Tax Assets
n/a
0
11
13
20
Derivative & Hedging Assets
n/a
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
Miscellaneous Long Term Assets
n/a
53
82
87
81
Total Noncurrent Assets
n/a
2,591
2,818
3,347
3,114
Total Assets
n/a
3,994
4,195
5,143
5,351
Liabilities and owners' equity
Payables & Accruals
n/a
429 428920000
503 502717000
523 522700000
621 620900000
Accounts Payable
n/a
267 267311000
343 343278000
317 317300000
382 382000000
Accrued Taxes
n/a
12 11665000
11 10551000
13 12900000
12 11600000
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
150 149944000
149 148888000
193 192500000
227 227300000
Short Term Debt
n/a
409 409000000
18 17770000
40 40100000
46 46200000
Short Term Borrowings
n/a
9 9000000
3 2770000
0 100000
5 5000000
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
400 400000000
15 15000000
40 40000000
41 41200000
Other Short Term Liabilities
n/a
85 84589000
86 85548000
90 89900000
82 82300000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 200000
Discontinued Operations
n/a
5 5370000
4 4093000
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
79 79219000
81 81455000
90 89900000
82 82100000
Total Current Liabilities
n/a
923 922509000
606 606035000
653 652700000
749 749400000
Long Term Debt
n/a
935 935000000
875 875000000
1,329 1329200000
1,928 1927800000
Long Term Borrowings
n/a
935 935000000
875 875000000
1,329 1329200000
1,928 1927800000
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
158 157554000
177 177199000
189 189400000
341 341000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
49 49346000
11 10601000
24 24100000
128 127800000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
108 108208000
167 166598000
165 165300000
213 213200000
Total Noncurrent Liabilities
n/a
1,093 1092554000
1,052 1052199000
1,519 1518600000
2,269 2268800000
Total Liabilities
n/a
2,015 2015063000
1,658 1658234000
2,171 2171300000
3,018 3018200000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
428 428457000
468 467661000
505 504700000
539 538500000
Common Stock
n/a
428 428457000
468 467661000
505 504700000
539 538500000
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
Retained Earnings
n/a
620 620439000
934 934333000
1,307 1306900000
1,716 1715900000
Other Equity
n/a
43 43200000
127 127050000
39 39400000
77 77000000
Equity Before Minority Interest
n/a
1,092 1092096000
1,529 1529044000
1,851 1851000000
2,331 2331400000
Minority Interest
n/a
2 1844000
2 1943000
2 1600000
1 1200000
Total Equity
n/a
1,094 1093940000
1,531 1530987000
1,853 1852600000
2,333 2332600000
Total Liabilities & Equity
n/a
3,109 3109003000
3,189 3189221000
4,024 4023900000
5,351 5350800000
Remarks restated on n/a restated on Aug 16, 2011 n/a restated on Aug 16, 2012 n/a restated on Aug 15, 2013 n/a restated on Nov 4, 2013 n/a
Cash Flow StatementCF data quality: 94% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13
Net Income/Starting Line
146
224
339
402
442
Net Income
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
Other Adjustments
0
0
0
0
0
Depreciation & Amortization
71
74
103
135
160
Non-Cash Items
35
15
-55
28
24
Stock-Based Compensation
10
15
15
19
18
Deferred Income Taxes
-1
-16
-56
28
6
Other Non-Cash Adjustments
26
17
-15
-18
-1
Change in Working Capital
-12
19
-13
-52
-72
(Increase) Decrease in Accounts Receivable
6
-22
-107
-49
-37
(Increase) Decrease in Inventories
7
-32
-30
5
-95
Increase (Decrease) in Accounts Payable
4
-2
58
-24
7
Increase (Decrease) in Other
-29
75
67
16
53
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
Cash from Operating Activities
240
332
374
513
554
Change in Fixed Assets & Intangibles
-58
-68
-110
-111
-104
Disposition of Fixed Assets & Intangibles
-57
-58
-99
-110
-104
Disposition of Fixed Assets
-57
-58
-99
-110
-104
Disposition of Intangible Assets
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
-1
-10
-11
-1
0
Purchase of Fixed Assets
-1
-10
-11
-1
0
Acquisition of Intangible Assets
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
Net Change in Long Term Investment
0
0
1
0
9
Decrease in Long Term Investment
0
0
1
0
9
Increase in Long Term Investment
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-88
-833
-1
-574
-852
Net Cash from Divestitures
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
Other Investing Activities
0
-19
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
Cash from Investing Activities
-147
-920
-111
-684
-948
Dividends Paid
-20
-22
-25
-29
-33
Cash From (Repayment of) Debt
-45
451
-51
477
602
Cash From (Repayment of) Short Term Debt, net
-14
-9
-6
-3
5
Cash From (Repayment of) Long Term Debt, net
-31
460
-45
479
597
Repayments of Long Term Debt
-31
-165
-195
-610
-40
Cash From Long Term Debt
0
625
150
1,089
637
Cash From (Repurchase of) Equity
-52
-50
6
3
-2
Increase in Capital Stock
10
21
14
12
11
Decrease in Capital Stock
-62
-71
-8
-8
-12
Other Financing Activities
2
4
12
8
10
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
Cash from Financing Activities
-115
383
-59
459
577
Net Cash Before Disc. Operations and FX
-22
-204
205
288
183
Change in Cash from Disc. Operations and Other
0
0
0
0
0
Net Cash Before FX
-22
-204
205
288
183
Effect of Foreign Exchange Rates
2
-4
-4
4
-6
Net Changes in Cash
-20
-208
200
292
178
Remarks
restated on Aug 16, 2011 n/a
calculated values,
restated on Aug 16, 2012 n/a
calculated values,
restated on Aug 15, 2013 n/a
calculated values,
restated on Aug 15, 2013 n/a
calculated values,
restated on Aug 15, 2013 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
About | Contact Forum | Legal
SimFin UG 2017 - Beta v. 1.42
Facebook | Twitter | Medium
Sumo